300 research outputs found

    Roadmap to Majorana surface codes

    Full text link
    Surface codes offer a very promising avenue towards fault-tolerant quantum computation. We argue that two-dimensional interacting networks of Majorana bound states in topological superconductor/semiconductor heterostructures hold several distinct advantages in that direction, both concerning the hardware realization and the actual operation of the code. We here discuss how topologically protected logical qubits in this Majorana surface code architecture can be defined, initialized, manipulated, and read out. All physical ingredients needed to implement these operations are routinely used in topologically trivial quantum devices. In particular, we show that by means of quantum interference terms in linear conductance measurements, composite single-electron pumping protocols, and gate-tunable tunnel barriers, the full set of quantum gates required for universal quantum computation can be implemented.Comment: 23 pages, 8 figure

    Towards realistic implementations of a Majorana surface code

    Full text link
    Surface codes have emerged as promising candidates for quantum information processing. Building on the previous idea to realize the physical qubits of such systems in terms of Majorana bound states supported by topological semiconductor nanowires, we show that the basic code operations, namely projective stabilizer measurements and qubit manipulations, can be implemented by conventional tunnel conductance probes and charge pumping via single-electron transistors, respectively. The simplicity of the access scheme suggests that a functional code might be in close experimental reach.Comment: 5 pages, 1 p. suppl.mat, PRL in pres

    A desktop expert system for the differential diagnosis of dementia:an evaluation study

    Get PDF
    Evince-I is a desktop expert system for the differential diagnosis of dementia, implemented on a personal computer. It is intended to assess the effectiveness of this new technology in modeling a psychiatrist who uses international guidelines for diagnosing dementia. EVINCE-I was tested in diagnosing 19 patients with varying stages of dementia and 10 patients showing other disorders except dementia. EVINCE-I and the human expert were in perfect agreement on the diagnosis of dementia and correlated highly on the diagnosis of dementia of the Alzheimer type and multiple infarct dementia. EVINCE-I thus offers important possibilities as a tool in investigating the data and procedures used by the human expert

    Differential diagnosis of dementia:a comparison between the expert system EVINCE and clinicians

    Get PDF
    The diagnostic performance of the expert system EVINCE was compared with that of 85 clinicians in diagnosing 10 patients suspected of suffering from dementia. A multidisciplinary expert committee provided a standard diagnosis as reference for comparison. The results showed that the syndrome and etiologic diagnoses made by EVINCE were in very close agreement with those of the expert committee and that the diagnostic performance of EVINCE was better than that of the average clinician. The present findings indicate that expert systems, especially those within the realm of complex multidimensional medical problems, could be a valuable aid in medical practice

    Lyapunov exponents in a Sachdev-Ye-Kitaev-type model with population imbalance in the conformal limit and beyond

    Full text link
    The Sachdev-Ye-Kitaev (SYK) model shows chaotic behavior with a maximal Lyapunov exponent. In this paper, we investigate the four-point function of a SYK-type model numerically, which gives us access to its Lyapunov exponent. The model consists of two sets of Majorana fermions, called A and B, and the interactions are restricted to being exclusively pairwise between the two sets, not within the sets. We find that the Lyapunov exponent is still maximal at strong coupling. Furthermore, we show that even though the conformal dimensions of the A and B fermions change with the population ratio, the Lyapunov exponent remains constant, not just in the conformal limit where it is maximal, but also in the intermediate and weak coupling regimes.Comment: 12 pages, 8 figures. Comments welcom

    Josephson diode effects in twisted nodal superconductors

    Full text link
    Recent Josephson tunneling experiments on twisted flakes of high-TcT_c cuprate superconductor Bi2_2Sr2_2CaCu2_2O8+x_{8+x} revealed a non-reciprocal behavior of the critical interlayer Josephson current - i.e., a Josephson diode effect. Motivated by these findings we study theoretically the emergence of the Josephson diode effect in twisted interfaces between nodal superconductors, and highlight a strong dependence on the twist angle θ\theta and damping of the junction. In all cases, the theory predicts diode efficiency that vanishes exactly at θ=45\theta = 45^\circ and has a strong peak at a twist angle close to θ=45\theta = 45^\circ, consistent with experimental observations. Near 4545^\circ, the junction breaks time-reversal symmetry T{\cal T} spontaneously. We find that for underdamped junctions showing hysteretic behavior, this results in a \emph{dynamical} Josephson diode effect in a part of the T{\cal T}-broken phase. The direction of the diode is trainable in this case by sweeping the external current bias. This effect provides a sensitive probe of spontaneous T{\cal T}-breaking. We then show that explicit T{\cal T}-breaking perturbations with the symmetry of a magnetic field perpendicular to the junction plane lead to a {\em thermodynamic} diode effect that survives even in the overdamped limit. We discuss an experimental protocol to probe the double-well structure in the Josephson free energy that underlies the tendency towards spontaneous T{\cal T}-breaking even if T{\cal T} is broken explicitly. Finally, we show that in-plane magnetic fields can control the diode effect in the short junction limit, and predict the signatures of explicit T{\cal T}-breaking in Shapiro steps

    Cancer incidence, treatment, and survival in the prison population compared with the general population in England: a population-based, matched cohort study

    Get PDF
    BACKGROUND: The growing and ageing prison population in England makes accurate cancer data of increasing importance for prison health policies. This study aimed to compare cancer incidence, treatment, and survival between patients diagnosed in prison and the general population. METHODS: In this population-based, matched cohort study, we used cancer registration data from the National Cancer Registration and Analysis Service in England to identify primary invasive cancers and cervical cancers in situ diagnosed in adults (aged ≥18 years) in the prison and general populations between Jan 1, 1998, and Dec 31, 2017. Ministry of Justice and Office for National Statistics population data for England were used to calculate age-standardised incidence rates (ASIR) per year and age-standardised incidence rate ratios (ASIRR) for the 20-year period. Patients diagnosed with primary invasive cancers (ie, excluding cervical cancers in situ) in prison between Jan 1, 2012, and Dec 31, 2017 were matched to individuals from the general population and linked to hospital and treatment datasets. Matching was done in a 1:5 ratio according to 5-year age group, gender, diagnosis year, cancer site, and disease stage. Our primary objectives were to compare the incidence of cancer (1998-2017); the receipt of treatment with curative intent (2012-17 matched cohort), using logistic regression adjusted for matching variables (excluding cancer site) and route to diagnosis; and overall survival following cancer diagnosis (2012-17 matched cohort), using a Cox proportional hazards model adjusted for matching variables (excluding cancer site) and route to diagnosis, with stratification for the receipt of any treatment with curative intent. FINDINGS: We identified 2015 incident cancers among 1964 adults (1556 [77·2%] men and 459 [22·8%] women) in English prisons in the 20-year period up to Dec 31, 2017. The ASIR for cancer for men in prison was initially lower than for men in the general population (in 1998, ASIR 119·33 per 100 000 person-years [95% CI 48·59-219·16] vs 746·97 per 100 000 person-years [742·31-751·66]), but increased to a similar level towards the end of the study period (in 2017, 856·85 per 100 000 person-years [675·12-1060·44] vs 788·59 per 100 000 person-years [784·62-792·57]). For women, the invasive cancer incidence rate was low and so ASIR was not reported for this group. Over the 20-year period, the incidence of invasive cancer for men in prison increased (incidence rate ratio per year, 1·05 [95% CI 1·04-1·06], during 1999-2017 compared with 1998). ASIRRs showed that over the 20-year period, overall cancer incidence was lower in men in prison than in men in the general population (ASIRR 0·76 [95% CI 0·73-0·80]). The difference was not statistically significant for women (ASIRR 0·83 [0·68-1·00]). Between Jan 1, 2012, and Dec 31, 2017, patients diagnosed in prison were less likely to undergo curative treatment than matched patients in the general population (274 [32·3%] of 847 patients vs 1728 [41·5%] of 4165; adjusted odds ratio (OR) 0·72 [95% CI 0·60-0·85]). Being diagnosed in prison was associated with a significantly increased risk of death on adjustment for matching variables (347 deaths during 2021·9 person-years in the prison cohort vs 1626 deaths during 10 944·2 person-years in the general population; adjusted HR 1·16 [95% CI 1·03-1·30]); this association was partly explained by stratification by curative treatment and further adjustment for diagnosis route (adjusted HR 1·05 [0·93-1·18]). INTERPRETATION: Cancer incidence increased in people in prisons in England between 1998 and 2017, with patients in prison less likely to receive curative treatments and having lower overall survival than the general population. The association with survival was partly explained by accounting for differences in receipt of curative treatment and adjustment for diagnosis route. Improved routine cancer surveillance is needed to inform prison cancer policies and decrease inequalities for this under-researched population. FUNDING: UK National Institute for Health and Care Research, King's College London, and Strategic Priorities Fund 2019/20 of Research England via the University of Surrey
    corecore